Sign in

    Robert Sessions

    Research Analyst at Water Tower Research

    Robert Sessions is an Equity Research Analyst at Water Tower Research, specializing in in-depth company analysis and strategic insights for investors. While at Water Tower Research, he has engaged with companies such as Sleep Optimization in the context of evaluating team structures and merger and acquisition strategies, showcasing his thorough approach to corporate fundamentals. Though detailed performance metrics and historical rankings are not publicly available, his analytical work reflects a commitment to informed, actionable research. Sessions’ further professional credentials, including FINRA registrations or securities licenses, and previous career history are not disclosed in available public sources.

    Robert Sessions's questions to Vivos Therapeutics (VVOS) leadership

    Robert Sessions's questions to Vivos Therapeutics (VVOS) leadership • Q2 2025

    Question

    Robert Sessions from Water Tower Research asked about the recruitment process for Sleep Optimization (SO) teams, the company's M&A strategy post-SCN, management's prior experience with similar models, plans for refinancing its recent debt, and the potential timeline to reach cash flow breakeven.

    Answer

    CEO Kirk Huntsman detailed the SO team recruitment process, noting a robust labor pool and highlighting the management team's deep experience with similar models from the dental service organization (DSO) industry. He affirmed they will pursue new M&A opportunities concurrently with the SCN integration. Regarding financing, Huntsman stated they are actively seeking to reduce the cost of capital as the new, more predictable business model matures. He expressed a strong push and hope to achieve cash flow positivity sometime in Q4 2025.

    Ask Fintool Equity Research AI